Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Objective Surgical is a private U.S. healthcare services company that organizes bundled surgical and diagnostic care, primarily for workers' compensation cases and self-funded employer health plans. Rather than developing therapeutics, it operates a vetted provider network and care-coordination model that delivers pre-negotiated global pricing, episode-of-care management, and simplified billing through a single responsible payer structure. Its offerings include surgical bundles, diagnostic scheduling for imaging and EMG/NCS studies, and the S.O.S. Card/Smart Option Services benefit for employer-sponsored plans. The company appears focused on orthopedic and related procedural care, emphasizing cost predictability, speed to treatment, and patient concierge support. For a biotech analyst, this is best characterized as a commercial healthcare delivery/managed-services business rather than a drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Objective Surgical.